Article | 21 Nov 2016
Life Sciences Report November 2016
In this issue of Life Sciences Report you can read about how it is possible to extend the term of protection for pharmaceutical products beyond the lifetime of a patent, as well as how a new judgement from the ECJ may turn the existing business models of pharmacies around Europe upside down.
We also provide you with an overview of the effects of Brexit to your intellectual property rights, insight to an EPO decision raising the bar for what to be considered an inventive step in patenting, what branding experts can learn from the Mc Trademark doctrine, and much more. Additionally, Lotta Törner, CEO of Livsmedelsakademin, looks into the future where the boundaries between food and medicine are blurring.
Enjoy your reading, and feel welcome to contact Setterwalls’ Life Science group for more information.
